FDA DEVICE FACTS
CORAIL Cemented Femoral Stem
Depuy Ireland UC
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The use of CORAIL Cemented Femoral Stems is indicated in Total and Hemi hip replacements. Total hip replacement is indicated in the following conditions:
1. A seve rely painful and/or disabled joint from osteoarthritis, traumatic arthritis, rheumatoid arthritis, or congenital hip dysplasia.
2. Avasc ular necrosis of the femoral head.
3. Acute traumatic fracture of the femoral head or neck.
4. Fai led previous hip surgery including joint reconstruction, internal fixation, arthrodesis, hemiarthroplasty, surface replacement arthroplasty, or total hip replacement.
5. C ertain cases of ankylosis. Par tial hip replacement or hip hemi-arthroplasty is indicated in the following conditions:
1. Acute fracture of the femoral head or neck that cannot be appropriately r educed and treated with internal fixation.
2. Avasc ular necrosis of the femoral head.
3. Non-union of femoral neck fractures.
4. C ertain high subcapital and femoral neck fractures in the elderly.
5. Degene rative arthritis involving only the femoral head in which the acetabulum does not require replacement.
6. Path ology involving only the femoral head/neck and/or proximal femur th at can be adequately treated by hip hemiarthroplasty. The CORAIL Cemented Femoral Stems are indicated only for use with bone cement.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。